<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35456065</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-0817</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>23</Day></PubDate></JournalIssue><Title>Pathogens (Basel, Switzerland)</Title><ISOAbbreviation>Pathogens</ISOAbbreviation></Journal><ArticleTitle>Superantigens and SARS-CoV-2.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">390</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/pathogens11040390</ELocationID><Abstract><AbstractText>It has been posited SARS-CoV-2 contains at least one unique superantigen-like motif not found in any other SARS or endemic coronaviruses. Superantigens are potent antigens that can send the immune system into overdrive. SARS-CoV-2 causes many of the biological and clinical consequences of a superantigen, and, in the context of reinfection and waning immunity, it is important to better understand the impact of a widely circulating, airborne pathogen that may be a superantigen, superantigen-like or trigger a superantigenic host response. Urgent research is needed to better understand the long-term risks being taken by governments whose policies enable widespread transmission of a potential superantigenic pathogen, and to more clearly define the vaccination and public health policies needed to protect against the consequences of repeat exposure to the pathogen.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hamdy</LastName><ForeName>Adam</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8565-0835</Identifier><AffiliationInfo><Affiliation>Panres Pandemic Research, Newport TF10 8PG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leonardi</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1865-9597</Identifier><AffiliationInfo><Affiliation>Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Pathogens</MedlineTA><NlmUniqueID>101596317</NlmUniqueID><ISSNLinking>2076-0817</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">coronavirus</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">neuroinvasion</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">reinfection</Keyword><Keyword MajorTopicYN="N">superantigen</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>23</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35456065</ArticleId><ArticleId IdType="pmc">PMC9026686</ArticleId><ArticleId IdType="doi">10.3390/pathogens11040390</ArticleId><ArticleId IdType="pii">pathogens11040390</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>White J., Herman A., Pullen A.M., Kubo R., Kappler J.W., Marrack P. The V Beta-Specific Superantigen Staphylococcal Enterotoxin B: Stimulation of Mature T Cells and Clonal Deletion in Neonatal Mice. Cell. 1989;56:27&#x2013;35. doi: 10.1016/0092-8674(89)90980-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(89)90980-X</ArticleId><ArticleId IdType="pubmed">2521300</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascual V., Capra J.D. B-Cell Superantigens? Curr. Biol. 1991;1:315&#x2013;317. doi: 10.1016/0960-9822(91)90097-G.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0960-9822(91)90097-G</ArticleId><ArticleId IdType="pubmed">15336109</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman G.J., Goodyear C.S. Confounding B-Cell Defences: Lessons From a Staphylococcal Superantigen. Nat. Rev. Immunol. 2006;6:465&#x2013;475. doi: 10.1038/nri1853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1853</ArticleId><ArticleId IdType="pubmed">16724100</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi Y., Lafferty J.A., Clements J.R., Todd J.K., Gelfand E.W., Kappler J., Marrack P., Kotzin B.L. Selective Expansion of T Cells Expressing V Beta 2 in Toxic Shock Syndrome. J. Exp. Med. 1990;172:981&#x2013;984. doi: 10.1084/jem.172.3.981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.172.3.981</ArticleId><ArticleId IdType="pmc">PMC2188536</ArticleId><ArticleId IdType="pubmed">2117641</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotzin B.L., Leung D.Y.M., Kappler J., Marrack P. Superantigens and Their Potential Role in Human Disease. Adv. Immunol. 1993;54:99&#x2013;166. doi: 10.1016/s0065-2776(08)60534-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0065-2776(08)60534-9</ArticleId><ArticleId IdType="pubmed">8397479</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotb M. Bacterial pyrogenic exotoxins as superantigens. Clin. Microbiol. Rev. 1995;8:411&#x2013;426. doi: 10.1128/CMR.8.3.411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.8.3.411</ArticleId><ArticleId IdType="pmc">PMC174633</ArticleId><ArticleId IdType="pubmed">7553574</ArticleId></ArticleIdList></Reference><Reference><Citation>Ericsson P.O., Hansson J., Widegren B., Dohlsten M., Sjogren H.O., Hedlund G. In vivo induction of gamma/delta T cells with highly potent and selective anti-tumor cytotoxicity. Eur. J. Immunol. 1996;21:2797&#x2013;2802. doi: 10.1002/eji.1830211122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.1830211122</ArticleId><ArticleId IdType="pubmed">1718760</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormack J.E., Callahan J.E., Kappler J., Marrack P.C. Profound deletion of mature T-cells in vivo by chronic exposure to exogenous superantigen. J. Immunol. 1993;150:3785&#x2013;3792.</Citation><ArticleIdList><ArticleId IdType="pubmed">8473733</ArticleId></ArticleIdList></Reference><Reference><Citation>Janik D.K., Lee W.T. Staphylococcal Enterotoxin B (SEB) Induces Memory CD4 T Cell Anergy in vivo and Impairs Recall Immunity to Unrelated Antigens. J. Clin. Cell Immunol. 2015;6:1&#x2013;8. doi: 10.4172/2155-9899.1000346.</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/2155-9899.1000346</ArticleId><ArticleId IdType="pmc">PMC4720977</ArticleId><ArticleId IdType="pubmed">26807307</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedez Y., Norrby-Teglund A., Low D., McGeer A., Kotb M. HLA class II alleles associated with outcome of invasive group A streptococcal infections; Proceedings of the 37th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy; Toronto, ON, Canada. 29 September&#x2013;1 October 1997.</Citation></Reference><Reference><Citation>Nadal D., Lauener R.P., Braegger C.P., Kaufhold A., Simma B., Lutticken R., Seger R.A. T-cell activation and cytokine release in streptococcal toxic shock-like syndrome. J. Pediatr. 1993;122:727&#x2013;729. doi: 10.1016/S0022-3476(06)80014-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3476(06)80014-4</ArticleId><ArticleId IdType="pubmed">8496751</ArticleId></ArticleIdList></Reference><Reference><Citation>Emmer A., Gerlach K., Staege M.S., Kornhuber M.E. In: Superantigen-Mediated Encephalitis. Hayasaka D., editor. InTech; Rijeka, Croatia: 2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.5772/20532</ArticleId></ArticleIdList></Reference><Reference><Citation>Kornhuber M.E., Emmer A., Gerlach K., Staege M.S. Experimental Models of Superantigen-Mediated Neuropathology. In: Kotb M., Fraser J.D., editors. Superantigens. ASM Press; Washington, DC, USA: 2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/9781555815844.ch11</ArticleId></ArticleIdList></Reference><Reference><Citation>Urbach-Ross D., Kusnecov A.W. Impact of superantigenic molecules on central nervous system function. Front. Biosci. 2009;14:4416&#x2013;4426. doi: 10.2741/3537.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/3537</ArticleId><ArticleId IdType="pubmed">19273359</ArticleId></ArticleIdList></Reference><Reference><Citation>Brogan P.A., Shah V., Klein N., Dillon M.J. Vbeta-restricted T cell adherence to endothelial cells: A mechanism for superantigen-dependent vascular injury. Arthritis Rheum. 2004;50:589&#x2013;597. doi: 10.1002/art.20021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.20021</ArticleId><ArticleId IdType="pubmed">14872503</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulhankova K., Kinney K.J., Stach J.M., Gourronc F.A., Grumbach I.A., Klingelhutz A.J., Salgado-Pabon W. The Superantigen Toxic Shock Syndrome Toxin 1 Alters Human Aortic Endothelial Cell Function. Infect. Immun. 2018;86:e00848-17. doi: 10.1128/IAI.00848-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.00848-17</ArticleId><ArticleId IdType="pmc">PMC5820935</ArticleId><ArticleId IdType="pubmed">29229737</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundstrom M., Abrahmsen L., Antonsson P., Mehindate K., Mourad W., Dohlsten M. The crystal structure of staphylococcal enterotoxin type D reveals Zn2+-mediated homodimerization. EMBO J. 1996;15:6832&#x2013;6840. doi: 10.1002/j.1460-2075.1996.tb01074.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1996.tb01074.x</ArticleId><ArticleId IdType="pmc">PMC452508</ArticleId><ArticleId IdType="pubmed">9003758</ArticleId></ArticleIdList></Reference><Reference><Citation>Jardetzky T., Brown J., Gorga J., Stern L., Urban R., Chi Y., Stauffacher C., Strominger J., Wiley D. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature. 1994;368:711&#x2013;718. doi: 10.1038/368711a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/368711a0</ArticleId><ArticleId IdType="pubmed">8152483</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Urban R., Strominger J., Wiley D. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science. 1994;266:1870&#x2013;1874. doi: 10.1126/science.7997880.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.7997880</ArticleId><ArticleId IdType="pubmed">7997880</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Shangiti A.M., Naylor C.E., Nair S.P., Briggs D.C., Henderson B., Chain B.M. Structural relationships and cellular tropism of staphylococcal superantigen-like proteins. Infect. Immun. 2004;72:4261&#x2013;4270. doi: 10.1128/IAI.72.7.4261-4270.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.72.7.4261-4270.2004</ArticleId><ArticleId IdType="pmc">PMC427445</ArticleId><ArticleId IdType="pubmed">15213171</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong P.C., Hu H., Rivera J., Rigby S., Chen Y.C., Howden B.P., Gardiner E., Peter K. Staphylococcal superantigen-like protein 5 induces thrombotic and bleeding complications in vivo: Inhibition by an anti-SSL5 antibody and the glycan Bimosiamose. J. Thromb. Haemost. JTH. 2012;10:2607&#x2013;2609. doi: 10.1111/jth.12022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.12022</ArticleId><ArticleId IdType="pubmed">23039170</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu H., Armstrong P.C., Khalil E., Chen Y.C., Straub A., Li M., Soosairajah J., Hagemeyer C.E., Bassler N., Huang D., et al. GPVI and GPIb&#x3b1; mediate staphylococcal superantigen-like protein 5 (SSL5) induced platelet activation and direct toward glycans as potential inhibitors. PLoS ONE. 2011;6:e19190. doi: 10.1371/journal.pone.0019190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0019190</ArticleId><ArticleId IdType="pmc">PMC3084272</ArticleId><ArticleId IdType="pubmed">21552524</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagnon S.J., Leporati A., Green S., Kalayanarooj S., Vaughn D.W., Stephens H.A., Suntayakorn S., Kurane I., Ennis F.A., Rothman A.L. T cell receptor Vbeta gene usage in Thai children with dengue virus infection. Am. J. Trop. Med. Hyg. 2001;64:41&#x2013;48. doi: 10.4269/ajtmh.2001.64.41.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.2001.64.41</ArticleId><ArticleId IdType="pubmed">11425161</ArticleId></ArticleIdList></Reference><Reference><Citation>Carod-Artal F.J., Wichmann O., Farrar J., Gasc&#xf3;n J. Neurological complications of dengue virus infection. Lancet Neurol. 2013;12:906&#x2013;919. doi: 10.1016/S1474-4422(13)70150-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70150-9</ArticleId><ArticleId IdType="pubmed">23948177</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan S.-W., Lin C.-F., Yeh T.-M., Liu C.-C., Liu H.-S., Wang S., Ling P., Anderson R., Lei H.-Y., Lin Y.-S. Autoimmunity in dengue pathogenesis. J. Formos. Med. Assoc. 2013;112:3&#x2013;11. doi: 10.1016/j.jfma.2012.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2012.11.006</ArticleId><ArticleId IdType="pubmed">23332423</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Qiu Y., Liu H., Liang B., Fan B., Zhou X., Liu D. Transcription profile of human endogenous retroviruses in response to dengue virus serotype 2 infection. Virology. 2020;544:21&#x2013;30. doi: 10.1016/j.virol.2020.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2020.01.014</ArticleId><ArticleId IdType="pubmed">32174511</ArticleId></ArticleIdList></Reference><Reference><Citation>Katzourakis A., Tristem M. Phylogeny of human endogenous and exogenous retroviruses. Retrovir. Primate Genome Evol. 2005;186:203.</Citation></Reference><Reference><Citation>Nelson P.N., Carnegie P.R., Martin J., Davari Ejtehadi H., Hooley P., Roden D., Rowland-Jones S., Warren P., Astley J. Demystified. Human endogenous retroviruses. Mol Pathol. 2003;56:11&#x2013;18. doi: 10.1136/mp.56.1.11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/mp.56.1.11</ArticleId><ArticleId IdType="pmc">PMC1187282</ArticleId><ArticleId IdType="pubmed">12560456</ArticleId></ArticleIdList></Reference><Reference><Citation>Posso-Osorio I., Tob&#xf3;n G.J., Ca&#xf1;as C.A. Human endogenous retroviruses (HERV) and non-HERV viruses incorporated into the human genome and their role in the development of autoimmune diseases. J. Transl. Autoimmun. 2021;4:100137. doi: 10.1016/j.jtauto.2021.100137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2021.100137</ArticleId><ArticleId IdType="pmc">PMC8669383</ArticleId><ArticleId IdType="pubmed">34917914</ArticleId></ArticleIdList></Reference><Reference><Citation>Posnett D.N., Yarilina A.A. Sleeping with the enemy&#x2014;Endogenous superantigens in humans. Immunity. 2001;15:503&#x2013;506. doi: 10.1016/S1074-7613(01)00211-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1074-7613(01)00211-4</ArticleId><ArticleId IdType="pubmed">11672533</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutkowski N., Conrad B., Thorley-Lawson D., Huber B.T. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity. 2001;15:579&#x2013;589. doi: 10.1016/S1074-7613(01)00210-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1074-7613(01)00210-2</ArticleId><ArticleId IdType="pubmed">11672540</ArticleId></ArticleIdList></Reference><Reference><Citation>Sicat J., Sutkowski N., Huber B.T. Expression of human endogenous retrovirus HERV-K18 superantigen is elevated in juvenile rheumatoid arthritis. J. Rheumatol. 2005;32:1821&#x2013;1831.</Citation><ArticleIdList><ArticleId IdType="pubmed">16142883</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Wang L., Liu H., Chen J., Liu D. Transcriptome Analyses Implicate Endogenous Retroviruses Involved in the Host Antiviral Immune System through the Interferon Pathway. Virol. Sin. 2021;36:1315&#x2013;1326. doi: 10.1007/s12250-021-00370-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-021-00370-2</ArticleId><ArticleId IdType="pmc">PMC8131884</ArticleId><ArticleId IdType="pubmed">34009516</ArticleId></ArticleIdList></Reference><Reference><Citation>Temerozo J., Fintelman-Rodrigues N., Santos M.C., Hottz E., Sacramento C., Silva A., Mandacaru S., Moraes E.C., Trugilho M., Gesto J., et al. Human Endogenous Retrovirus K Activation in the Lower Respiratory Tract of Severe COVID-19 Patients Associates with Early Mortality. Res. Sq. 2021;21:514541. doi: 10.21203/rs.3.rs-514541/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-514541/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Balestrieri E., Minutolo A., Petrone V., Fanelli M., Iannetta M., Malagnino V., Zordan M., Vitale P., Charvet B., Horvat B., et al. Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients. EBioMedicine. 2021;66:103341. doi: 10.1016/j.ebiom.2021.103341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103341</ArticleId><ArticleId IdType="pmc">PMC8082064</ArticleId><ArticleId IdType="pubmed">33867312</ArticleId></ArticleIdList></Reference><Reference><Citation>Charvet B., Brunel J., Pierquin J., Iampietro M., Decimo D., Queruel N., Lucas A., Encabo-Berzosa M., Arenaz I., Marmolejo T.P., et al.  SARS-CoV-2 induces human endogenous retrovirus type W envelope protein expression in blood lymphocytes and in tissues of COVID-19 patients.  [(accessed on 7 February 2022)];medRxiv. 2022  Available online:  https://www.medrxiv.org/content/10.1101/2022.01.18.21266111v2.full.pdf.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.18.21266111v2.full.pdf</ArticleId></ArticleIdList></Reference><Reference><Citation>Perron H., Jouvin-Marche E., Michel M., Ounanian-Paraz A., Camelo S., Dumon A., Jolivet-Reynaud C., Marcel F., Souillet Y., Borel E., et al. Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal V&#x3b2;16 T-lymphocyte activation. Virology. 2001;287:321&#x2013;332. doi: 10.1006/viro.2001.1045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2001.1045</ArticleId><ArticleId IdType="pubmed">11531410</ArticleId></ArticleIdList></Reference><Reference><Citation>Deacy A.M., Gan S.K.-E., Derrick J.P. Superantigen Recognition and Interactions: Functions, Mechanisms and Applications. Front. Immunol. 2021;12:1845. doi: 10.3389/fimmu.2021.731845.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.731845</ArticleId><ArticleId IdType="pmc">PMC8488440</ArticleId><ArticleId IdType="pubmed">34616400</ArticleId></ArticleIdList></Reference><Reference><Citation>Miethke T., Wahl C., Heeg K., Wagner H. Acquired resistance to superantigen-induced T cell shock. V beta selective T cell unresponsiveness unfolds directly from a transient state of hyperreactivity. J. Immunol. 1993;150:3776&#x2013;3784.</Citation><ArticleIdList><ArticleId IdType="pubmed">8473732</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuroda K., Yagi J., Imanishi K., Yan X.J., Li X.Y., Fujimaki W., Kato H., Miyoshi-Akiyama T., Kumazawa Y., Abe H., et al. Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen. J. Immunol. 1996;157:1422&#x2013;1431.</Citation><ArticleIdList><ArticleId IdType="pubmed">8759722</ArticleId></ArticleIdList></Reference><Reference><Citation>Meilleur C.E., Wardell C.M., Mele T.S., Dikeakos J.D., Bennink J.R., Mu H., McCormick J.K., Mansour Haeryfar S.M. Bacterial Superantigens Expand and Activate, Rather than Delete or Incapacitate, Preexisting Antigen-Specific Memory CD8+ T Cells. J. Infect. Dis. 2019;219:1307&#x2013;1317. doi: 10.1093/infdis/jiy647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiy647</ArticleId><ArticleId IdType="pmc">PMC6452305</ArticleId><ArticleId IdType="pubmed">30418594</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteside S.K., Snook J.P., Williams M.A., Weis J.J. Bystander T Cells: A Balancing Act of Friends and Foes. Trends Immunol. 2018;39:1021&#x2013;1035. doi: 10.1016/j.it.2018.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2018.10.003</ArticleId><ArticleId IdType="pmc">PMC6269193</ArticleId><ArticleId IdType="pubmed">30413351</ArticleId></ArticleIdList></Reference><Reference><Citation>Tough D.F., Borrow P., Sprent J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science. 1996;272:1947&#x2013;1950. doi: 10.1126/science.272.5270.1947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.272.5270.1947</ArticleId><ArticleId IdType="pubmed">8658169</ArticleId></ArticleIdList></Reference><Reference><Citation>Coppola M.A., Blackman M.A. Bacterial superantigens reactivate antigen-specific CD8+ memory T cells. Int. Immunol. 1997;9:1393&#x2013;1403. doi: 10.1093/intimm/9.9.1393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/9.9.1393</ArticleId><ArticleId IdType="pubmed">9310843</ArticleId></ArticleIdList></Reference><Reference><Citation>Biasi G., Panozzo M., Pertile P., Mezzalira S., Facchinetti A. Mechanism underlying superantigen-induced clonal deletion of mature T lymphocytes. Int. Immunol. 1994;6:983&#x2013;989. doi: 10.1093/intimm/6.7.983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/6.7.983</ArticleId><ArticleId IdType="pubmed">7947466</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehl S., Hombach J., Aichele P., Hengartner H., Zinkernagel R.M. Bystander activation of cytotoxic T cells: Studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model. J. Exp. Med. 1997;185:1241&#x2013;1251. doi: 10.1084/jem.185.7.1241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.185.7.1241</ArticleId><ArticleId IdType="pmc">PMC2196250</ArticleId><ArticleId IdType="pubmed">9104811</ArticleId></ArticleIdList></Reference><Reference><Citation>Halnon N.J., Jamieson B., Plunkett M., Kitchen C.M., Pham T., Krogstad P. Thymic function and impaired maintenance of peripheral T cell populations in children with congenital heart disease and surgical thymectomy. Pediatr. Res. 2005;57:42&#x2013;48. doi: 10.1203/01.PDR.0000147735.19342.DE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1203/01.PDR.0000147735.19342.DE</ArticleId><ArticleId IdType="pubmed">15531736</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer S., Albergante L., Blackburn C.C., Newman T.J. Thymic involution and rising disease incidence with age. Proc. Natl. Acad. Sci. USA. 2018;115:1883&#x2013;1888. doi: 10.1073/pnas.1714478115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1714478115</ArticleId><ArticleId IdType="pmc">PMC5828591</ArticleId><ArticleId IdType="pubmed">29432166</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M., Patel S.K., Juno J.A., Burrell L.M., Kent S.J., Dore G.J., et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M., Yao D., Zeng X., Kasakovski D., Zhang Y., Chen S., Zha X., Li Y., Xu L. Age related human T cell subset evolution and senescence. Immun. Ageing. 2019;16:24. doi: 10.1186/s12979-019-0165-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-019-0165-8</ArticleId><ArticleId IdType="pmc">PMC6739976</ArticleId><ArticleId IdType="pubmed">31528179</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaech S., Wherry E., Ahmed R. Effector and memory T-cell differentiation: Implications for vaccine development. Nat. Rev. Immunol. 2002;2:251&#x2013;262. doi: 10.1038/nri778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri778</ArticleId><ArticleId IdType="pubmed">12001996</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicin-Sain L., Smyk-Pearson S., Currier N., Byrd L., Koudelka C., Robinson T., Swarbrick G., Tackitt S., Legasse A., Fischer M., et al. Loss of naive T cells and repertoire constriction predict poor response to vaccination in old primates. J. Immunol. 2010;184:6739&#x2013;6745. doi: 10.4049/jimmunol.0904193.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0904193</ArticleId><ArticleId IdType="pmc">PMC3504654</ArticleId><ArticleId IdType="pubmed">20483749</ArticleId></ArticleIdList></Reference><Reference><Citation>Yarwood J.M., Leung D.Y., Schlievert P.M. Evidence for the involvement of bacterial superantigens in psoriasis, atopic dermatitis, and Kawasaki syndrome. FEMS Microbiol. Lett. 2000;192:1&#x2013;7. doi: 10.1111/j.1574-6968.2000.tb09350.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6968.2000.tb09350.x</ArticleId><ArticleId IdType="pubmed">11040420</ArticleId></ArticleIdList></Reference><Reference><Citation>Conrad B., Weissmahr R.N., B&#xf6;ni J., Arcari R., Sch&#xfc;pbach J., Mach B. A Human Endogenous Retroviral Superantigen as Candidate Autoimmune Gene in Type I Diabetes. Cell. 1997;90:303&#x2013;313. doi: 10.1016/S0092-8674(00)80338-4. ISSN 0092-8674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)80338-4</ArticleId><ArticleId IdType="pubmed">9244304</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman S.M., Posnett D.N., Tumang J.R., Cole B.C., Crow M.K. A potential role for microbial superantigens in the pathogenesis of systemic autoimmune disease. Arthritis Rheum. 1991;34:468&#x2013;480. doi: 10.1002/art.1780340412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780340412</ArticleId><ArticleId IdType="pubmed">1826427</ArticleId></ArticleIdList></Reference><Reference><Citation>Acha-Orbea H. Bacterial and viral superantigens: Roles in autoimmunity? Ann. Rheum. Dis. 1993;52:S6&#x2013;S16. doi: 10.1136/ard.52.Suppl_1.S6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.52.Suppl_1.S6</ArticleId><ArticleId IdType="pmc">PMC1035021</ArticleId><ArticleId IdType="pubmed">8481060</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman G.J. B cell superantigens: Possible roles in immunodeficiency and autoimmunity. Semin. Immunol. 1998;10:43&#x2013;55. doi: 10.1006/smim.1997.0104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/smim.1997.0104</ArticleId><ArticleId IdType="pubmed">9529655</ArticleId></ArticleIdList></Reference><Reference><Citation>Soos J.M., Schiffenbauer J., Torres B.A., Johnson H.M. Superantigens as virulence factors in autoimmunity and immunodeficiency diseases. Med. Hypotheses. 1997;48:253&#x2013;259. doi: 10.1016/S0306-9877(97)90315-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0306-9877(97)90315-7</ArticleId><ArticleId IdType="pubmed">9140890</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Llera A., Malchiodi E.L., Mariuzza R.A. The structural basis of T-cell activation by superantigens. Ann. Rev. Immunol. 1999;17:435&#x2013;466. doi: 10.1146/annurev.immunol.17.1.435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.17.1.435</ArticleId><ArticleId IdType="pubmed">10358765</ArticleId></ArticleIdList></Reference><Reference><Citation>Stollerman G.H. Rheumatogenic group A streptococci and the return of rheumatic fever. Adv. Intern. Med. 1990;35:1&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">2405590</ArticleId></ArticleIdList></Reference><Reference><Citation>Domiati-Saad R., Attrep J.F., Brezinschek H.P., Cherrie A.H., Karp D.R., Lipsky P.E. Staphylococcal enterotoxin D functions as a human B-cell superantigen by rescuing VH4-expressing B-cells from apoptosis. J. Immunol. 1996;156:3608&#x2013;3620.</Citation><ArticleIdList><ArticleId IdType="pubmed">8621894</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofer M.F., Newell K., Duke R.C., Schlievert P.M., Freed J.H., Leung D.Y.M. Differential effects of staphylococcal toxic shock syndrome toxin 1 on B cell apoptosis. Proc. Natl. Acad. Sci. USA. 1996;93:5425&#x2013;5430. doi: 10.1073/pnas.93.11.5425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.11.5425</ArticleId><ArticleId IdType="pmc">PMC39262</ArticleId><ArticleId IdType="pubmed">8643591</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhary V.R., Tilahun A.Y., Clark C.R., Grande J.P., Rajagopalan G. Chronic exposure to staphylococcal superantigen elicits a systemic inflammatory disease mimicking lupus. J. Immunol. 2012;189:2054&#x2013;2062. doi: 10.4049/jimmunol.1201097.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1201097</ArticleId><ArticleId IdType="pmc">PMC3462343</ArticleId><ArticleId IdType="pubmed">22798666</ArticleId></ArticleIdList></Reference><Reference><Citation>Dar S.A., Janahi E.M., Haque S., Akhter N., Jawed A., Wahid M., Ramachandran V.G., Bhattacharya S.N., Banerjee B.D., Das S. Superantigen influence in conjunction with cytokine polymorphism potentiates autoimmunity in systemic lupus erythematosus patients. Immunol. Res. 2016;64:1001&#x2013;1012. doi: 10.1007/s12026-015-8768-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-015-8768-4</ArticleId><ArticleId IdType="pubmed">26676360</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekigawa I., Ogasawara H., Kaneko H., Hishikawa T., Hashimoto H. Retroviruses and autoimmunity. Intern. Med. 2001;40:80&#x2013;86. doi: 10.2169/internalmedicine.40.80.</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.40.80</ArticleId><ArticleId IdType="pubmed">11300167</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogasawara H., Naito T., Kaneko H., Hishikawa T., Sekigawa I., Hashimoto H., Kaneko Y., Yamamoto N., Maruyama N., Yamamoto N. Quantitative analyses of messenger RNA of human endogenous retrovirus in patients with systemic lupus erythematosus. J. Rheumatol. 2001;28:533&#x2013;538.</Citation><ArticleIdList><ArticleId IdType="pubmed">11296954</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitsou K., Kotanidou A., Paraskevis D., Karamitros T., Katzourakis A., Tedder R., Hurst T., Sapounas S., Kotsinas A., Gorgoulis V., et al. Upregulation of Human Endogenous Retroviruses in Bronchoalveolar Lavage Fluid of COVID-19 Patients. Microbiol. Spectr. 2021;9:e01260-21. doi: 10.1128/Spectrum.01260-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/Spectrum.01260-21</ArticleId><ArticleId IdType="pmc">PMC8510252</ArticleId><ArticleId IdType="pubmed">34612698</ArticleId></ArticleIdList></Reference><Reference><Citation>Levet S., Medina J., Joanou J., Demolder A., Queruel N., Reant K., Normand M., Seffals M., Dimier J., Germi R., et al. An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes. JCI Insight. 2017;2:17. doi: 10.1172/jci.insight.94387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.94387</ArticleId><ArticleId IdType="pmc">PMC5621895</ArticleId><ArticleId IdType="pubmed">28878130</ArticleId></ArticleIdList></Reference><Reference><Citation>Niegowska M., Wajda-Cuszlag M., Stepien-Ptak G., Trojanek J., Micha&#x142;kiewicz J., Szalecki M., Sechi L. Anti-HERV-WEnv antibodies are correlated with seroreactivity against Mycobacterium avium subsp. paratuberculosis in children and youths at T1D risk. Sci. Rep. 2019;9:6282. doi: 10.1038/s41598-019-42788-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-42788-5</ArticleId><ArticleId IdType="pmc">PMC6472397</ArticleId><ArticleId IdType="pubmed">31000760</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan T., Cao G., Tang E., Zhao Y., Penaloza-MacMaster P., Fang Y., Huang J. A single-cell atlas reveals shared and distinct immune responses and metabolism during SARS-CoV-2 and HIV-1 infections.  [(accessed on 7 February 2022)];bioRxiv. 2022  Available online:  https://www.biorxiv.org/content/10.1101/2022.01.10.475725v1.full.pdf.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.10.475725v1.full.pdf</ArticleId><ArticleId IdType="pmc">PMC10040851</ArticleId><ArticleId IdType="pubmed">36992700</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E.Y., Mao T., Klein J., Dai Y., Huck J.D., Jaycox J.R., Liu F., Zhou T., Israelow B., Wong P., et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595:283&#x2013;288. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Muratori P., Lenzi M., Muratori L., Granito A. Antinuclear antibodies in COVID 19. Clin. Transl. Sci. 2021;14:1627&#x2013;1628. doi: 10.1111/cts.13026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cts.13026</ArticleId><ArticleId IdType="pmc">PMC8239781</ArticleId><ArticleId IdType="pubmed">33932091</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouo T., Chaisawangwong W. SARS-CoV-2 as a superantigen in multisystem inflammatory syndrome in children. J. Clin. Investig. 2021;131:e149327. doi: 10.1172/JCI149327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI149327</ArticleId><ArticleId IdType="pmc">PMC8121522</ArticleId><ArticleId IdType="pubmed">33844652</ArticleId></ArticleIdList></Reference><Reference><Citation>Rha M.S., Shin E.C. Activation or exhaustion of CD8+ T cells in patients with COVID-19. Cell Mol. Immunol. 2021;18:2325&#x2013;2333. doi: 10.1038/s41423-021-00750-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-021-00750-4</ArticleId><ArticleId IdType="pmc">PMC8374113</ArticleId><ArticleId IdType="pubmed">34413488</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottesman B.L., Yu J., Tanaka C., Longhurst C.A., Kim J.J. Incidence of New-Onset Type 1 Diabetes Among US Children During the COVID-19 Global Pandemic. JAMA Pediatr. 2022;24:5801. doi: 10.1001/jamapediatrics.2021.5801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2021.5801</ArticleId><ArticleId IdType="pmc">PMC8787677</ArticleId><ArticleId IdType="pubmed">35072727</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow D., Stein S., Ramelli S., Grazioli A., Chung J., Singh M., Yinda C.K., Winkler C., Dickey J., Ylaya K., et al.  SARS-CoV-2 infection and persistence throughout the human body and brain.  [(accessed on 7 February 2022)].  Available online:  https://www.researchsquare.com/article/rs-1139035/v1.</Citation></Reference><Reference><Citation>de Melo G.D., Lazarini F., Levallois S., Hautefort C., Michel V., Larrous F., Verillaud B., Aparicio C., Wagner S., Gheusi G., et al. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci. Transl. Med. 2021;13:eabf8396. doi: 10.1126/scitranslmed.abf8396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abf8396</ArticleId><ArticleId IdType="pmc">PMC8158965</ArticleId><ArticleId IdType="pubmed">33941622</ArticleId></ArticleIdList></Reference><Reference><Citation>Vibholm L.K., Nielsen S.S.F., Pahus M.H., Frattari G.S., Olesen R., Andersen R., Monrad I., Andersen A.H.F., Thomsen M.M., Konrad C.V., et al. SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses. EBioMedicine. 2021;64:103230. doi: 10.1016/j.ebiom.2021.103230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103230</ArticleId><ArticleId IdType="pmc">PMC7847186</ArticleId><ArticleId IdType="pubmed">33530000</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C., Wang Z., Lorenzi J.C.C., Muecksch F., Finkin S., Tokuyama M., Cho A., Jankovic M., Schaefer-Babajew D., Oliveira T.Y., et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639&#x2013;644. doi: 10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy R., Farber N., Kresch E., Seetharam D., Diaz P., Ramasamy R. SARS-CoV-2 in the Prostate: Immunohistochemical and Ultrastructural Studies. World J. Men&#x2019;s Health. 2022;40:e12. doi: 10.5534/wjmh.210174.</Citation><ArticleIdList><ArticleId IdType="doi">10.5534/wjmh.210174</ArticleId><ArticleId IdType="pmc">PMC8987136</ArticleId><ArticleId IdType="pubmed">35021303</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Cardona A., Lloreta Trull J., Albero-Gonz&#xe1;lez R., Beser M.P., And&#xfa;jar X., Ruiz-Ramirez P., Tur-Mart&#xed;nez J., Ferrer C., De Marcos Izquierdo J.A., Madrigal A.P., et al. SARS-CoV-2 identified by transmission electron microscopy in lymphoproliferative and ischaemic intestinal lesions of COVID-19 patients with acute abdominal pain: Two case reports. BMC Gastroenterol. 2021;21:334. doi: 10.1186/s12876-021-01905-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12876-021-01905-3</ArticleId><ArticleId IdType="pmc">PMC8390036</ArticleId><ArticleId IdType="pubmed">34445965</ArticleId></ArticleIdList></Reference><Reference><Citation>Arostegui D., Castro K., Schwarz S., Vaidy K., Rabinowitz S., Wallach T. Persistent SARS-CoV-2 Nucleocapsid Protein Presence in the Intestinal Epithelium of a Pediatric Patient 3 Months After Acute Infection. PGN Rep. 2021;3:e152. doi: 10.1097/PG9.0000000000000152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PG9.0000000000000152</ArticleId><ArticleId IdType="pmc">PMC10158423</ArticleId><ArticleId IdType="pubmed">37168753</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng M.H., Zhang S., Porritt R.A., Rivas M.N., Paschold L., Willscher E., Binder M., Arditi M., Bahar I. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation. Proc. Natl. Acad. Sci. USA. 2020;117:25254&#x2013;25262. doi: 10.1073/pnas.2010722117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2010722117</ArticleId><ArticleId IdType="pmc">PMC7568239</ArticleId><ArticleId IdType="pubmed">32989130</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste L., Roels L., Naesens L., Bosteels V., Vanhee S., Dupont S., Bosteels C., Browaeys R., Vandamme N., Verstaen K., et al. TIM3+ TRBV11-2 T cells and IFN&#x3b3; signature in patrolling monocytes and CD16+ NK cells delineate MIS&#x2013;C. J. Exp. Med. 2022;219:e20211381. doi: 10.1084/jem.20211381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20211381</ArticleId><ArticleId IdType="pmc">PMC8685281</ArticleId><ArticleId IdType="pubmed">34914824</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreews M., Le Gouge K., Khaldi-Plassart S., Pescarmona R., Mathieu A.L., Malcus C., Djebali S., Bellomo A., Dauwalder O., Perret M., et al. Polyclonal expansion of TCR Vb 21.3+ CD4+ and CD8+ T cells is a hallmark of multisystem inflammatory syndrome in children. Sci. Immunol. 2021;6:eabh1516. doi: 10.1126/sciimmunol.abh1516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abh1516</ArticleId><ArticleId IdType="pmc">PMC8815705</ArticleId><ArticleId IdType="pubmed">34035116</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P. SARS-CoV-2 infections in children: Understanding diverse outcomes. Immunity. 2022;55:201&#x2013;209. doi: 10.1016/j.immuni.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8769938</ArticleId><ArticleId IdType="pubmed">35093190</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris S.B., Schwartz N.G., Patel P., Abbo L., Beauchamps L., Balan S., Lee E.H., Paneth-Pollak R., Geevarughese A., Lash M.K., et al. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection&#x2014;United Kingdom and United States, March-August 2020. MMWR Morb. Mortal. Wkly. Rep. 2020;69:1450&#x2013;1456. doi: 10.15585/mmwr.mm6940e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6940e1</ArticleId><ArticleId IdType="pmc">PMC7561225</ArticleId><ArticleId IdType="pubmed">33031361</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomard-Mennesson E., Landron C., Dauphin C., Epaulard O., Petit C., Green L., Roblot P., Lusson J.-R., Broussolle C., S&#xe8;ve P. Kawasaki Disease in Adults. Medicine. 2010;89:149&#x2013;158. doi: 10.1097/MD.0b013e3181df193c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0b013e3181df193c</ArticleId><ArticleId IdType="pubmed">20453601</ArticleId></ArticleIdList></Reference><Reference><Citation>Kontopoulou T., Kontopoulos D.G., Vaidakis E., Mousoulis G.P. Adult Kawasaki disease in a European patient: A case report and review of the literature. J. Med. Case Rep. 2015;9:75. doi: 10.1186/s13256-015-0516-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13256-015-0516-9</ArticleId><ArticleId IdType="pmc">PMC4403952</ArticleId><ArticleId IdType="pubmed">25890055</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaglioni V., Soriano E.R. Are superantigens the cause of cytokine storm and viral sepsis in severe COVID-19? Observations and hypothesis. Scand. J. Immunol. 2020;92:e12944. doi: 10.1111/sji.12944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sji.12944</ArticleId><ArticleId IdType="pmc">PMC7404497</ArticleId><ArticleId IdType="pubmed">32697367</ArticleId></ArticleIdList></Reference><Reference><Citation>Porritt R.A., Paschold L., Rivas M.N., Cheng M.H., Yonker L.M., Chandnani H., Lopez M., Simnica D., Schulthei&#xdf; C., Santiskulvong C., et al. HLA class I-associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children. J. Clin. Investig. 2021;131:e146614. doi: 10.1172/JCI146614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI146614</ArticleId><ArticleId IdType="pmc">PMC8121516</ArticleId><ArticleId IdType="pubmed">33705359</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Icazbalceta G., Hussain Z., V&#xe9;lez-Alavez M. In silico evidence of superantigenic features in ORF8 protein from COVID-19.  [(accessed on 7 February 2022)];bioRxiv. 2021  Available online:  https://www.biorxiv.org/content/10.1101/2021.12.14.472240v1.full.pdf.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.12.14.472240v1.full.pdf</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiappelli F. Comments on &#x201c;An insertion unique to SARS-CoV-2 exhibits super antigenic character strengthened by recent mutations&#x201d; by Cheng MH et al. 2020. Bioinformation. 2020;16:474&#x2013;476. doi: 10.6026/97320630016474.</Citation><ArticleIdList><ArticleId IdType="doi">10.6026/97320630016474</ArticleId><ArticleId IdType="pmc">PMC7452748</ArticleId><ArticleId IdType="pubmed">32884212</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng M.H., Porritt R.A., Rivas M.N. A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro. Structure. 2021;29:951.e3&#x2013;962.e3. doi: 10.1016/j.str.2021.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2021.04.005</ArticleId><ArticleId IdType="pmc">PMC8082696</ArticleId><ArticleId IdType="pubmed">33930306</ArticleId></ArticleIdList></Reference><Reference><Citation>Bittmann S., Weissenstein A., Luchter E., Mosch&#xfc;ring-Alieva Villalon G. Multisystem inflammatory syndrome in children (MIS&#x2013;C): The role of viral superantigens in COVID-19 disease. J. Allergy Infect. Dis. 2020;1:18&#x2013;20.</Citation></Reference><Reference><Citation>Tang Y., Liu J., Zhang D., Xu Z., Ji J., Wen C. Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies. Front. Immunol. 2020;11:1708. doi: 10.3389/fimmu.2020.01708.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01708</ArticleId><ArticleId IdType="pmc">PMC7365923</ArticleId><ArticleId IdType="pubmed">32754163</ArticleId></ArticleIdList></Reference><Reference><Citation>Guimar&#xe3;es D., Pissarra R., Reis-Melo A., Guimar&#xe3;es H. Multisystem inflammatory syndrome in children (MISC): A systematic review. Int. J. Clin. Pract. 2021;75:e14450. doi: 10.1111/ijcp.14450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14450</ArticleId><ArticleId IdType="pubmed">34105843</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Riitano F., Valentini P. Pediatric Inflammatory Multisystem Syndrome Temporally Related With SARS-CoV-2: Immunological Similarities With Acute Rheumatic Fever and Toxic Shock Syndrome. Front. Pediatr. 2020;8 doi: 10.3389/fped.2020.00574.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2020.00574</ArticleId><ArticleId IdType="pmc">PMC7516715</ArticleId><ArticleId IdType="pubmed">33042918</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung R.S.M. The etiology of Kawasaki disease: A superantigen-mediated process. Prog. Pediatr. Cardiol. 2004;19:115&#x2013;122. doi: 10.1016/j.ppedcard.2004.08.004. ISSN 1058-9813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ppedcard.2004.08.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi O.L., Hughes S.E., Turner G., Rivera S.C., McMullan C., Chandan J.S., Haroon S., Price G., Davies E.H., Nirantharakumar K., et al. Symptoms, complications and management of long COVID: A review. J. R. Soc. Med. 2021;114:428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynall M. Neuropsychiatric symptoms in lupus. Lupus. 2018;27((Suppl. 1)):18&#x2013;20. doi: 10.1177/0961203318801672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203318801672</ArticleId><ArticleId IdType="pubmed">30452327</ArticleId></ArticleIdList></Reference><Reference><Citation>Leuchten N., Milke B., Winkler-Rohlfing B., Daikh D., D&#xf6;rner T., Johnson S.R., Aringer M. Early symptoms of systemic lupus erythematosus (SLE) recalled by 339 SLE patients. Lupus. 2018;27:1431&#x2013;1436. doi: 10.1177/0961203318776093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203318776093</ArticleId><ArticleId IdType="pubmed">29771193</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettersson S., L&#xf6;vgren M., Eriksson L.E., Moberg C., Svenungsson E., Gunnarsson I., Henriksson E.W. An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life. Scand. J. Rheumatol. 2012;41:383&#x2013;390. doi: 10.3109/03009742.2012.677857.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/03009742.2012.677857</ArticleId><ArticleId IdType="pubmed">22646821</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J., Waterboer T., Hippchen T., Simon J., Kirchner M., Lim A., M&#xfc;ller B., Merle U. Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study. Clin. Infect. Dis. 2021 doi: 10.1093/cid/ciab611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Zong F., Gan C., Wang Y., Su D., Deng M., Xiao N., Zhang Z., Zhou D., Gao B., Yang H. Exposure to aerosolized staphylococcal enterotoxin B potentiated by lipopolysaccharide modifies lung transcriptomes and results in lung injury in the mouse model. J. Appl. Toxicol. 2022;11:4289. doi: 10.1002/jat.4289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jat.4289</ArticleId><ArticleId IdType="pubmed">35080034</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma L., Riva A. Intestinal Barrier Function in Health and Disease-Any role of SARS-CoV-2? Microorganisms. 2020;8:1744. doi: 10.3390/microorganisms8111744.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8111744</ArticleId><ArticleId IdType="pmc">PMC7694956</ArticleId><ArticleId IdType="pubmed">33172188</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh S.S., Wang J., Yannie P.J., Ghosh S. Intestinal Barrier Dysfunction, LPS Translocation, and Disease Development. J. Endocr. Soc. 2020;4:bvz039. doi: 10.1210/jendso/bvz039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jendso/bvz039</ArticleId><ArticleId IdType="pmc">PMC7033038</ArticleId><ArticleId IdType="pubmed">32099951</ArticleId></ArticleIdList></Reference><Reference><Citation>Devaux C.A., Lagier J.C., Raoult D. New Insights Into the Physiopathology of COVID-19: SARS-CoV-2-Associated Gastrointestinal Illness. Front. Med. 2021;8:640073. doi: 10.3389/fmed.2021.640073.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.640073</ArticleId><ArticleId IdType="pmc">PMC7930624</ArticleId><ArticleId IdType="pubmed">33681266</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Zhou Y., Jiang N., Zhou Q., Ma W.L. Persistence of intestinal SARS-CoV-2 infection in patients with COVID-19 leads to re-admission after pneumonia resolved. Int. J. Infect. Dis. 2020;95:433&#x2013;435. doi: 10.1016/j.ijid.2020.04.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.04.063</ArticleId><ArticleId IdType="pmc">PMC7184976</ArticleId><ArticleId IdType="pubmed">32353545</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Donnell J.S., Chappell K.J. Chronic SARS-CoV-2, a Cause of Post-acute COVID-19 Sequelae (Long-COVID)? Front. Microbiol. 2021;12:64. doi: 10.3389/fmicb.2021.724654.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.724654</ArticleId><ArticleId IdType="pmc">PMC8365243</ArticleId><ArticleId IdType="pubmed">34408742</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinot R., Hubert M., de Melo G.D., Lazarini F., Bruel T., Smith N., Levallois S., Larrous F., Fernandes J., Gellenoncourt S., et al. SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance. Nat. Commun. 2021;12:4354. doi: 10.1038/s41467-021-24521-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24521-x</ArticleId><ArticleId IdType="pmc">PMC8285531</ArticleId><ArticleId IdType="pubmed">34272374</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira P.C., Dorneles G.P., Santana Filho P.C., da Silva I.M., Schipper L.L., Postiga I.A.L., Moreira Neves C.A., Rodrigues Junior L.C., Peres A., Trindade de Souto J., et al. Increased LPS levels coexist with systemic inflammation and result in monocyte activation in severe COVID-19 patients. Int. Immunopharmacol. 2021;100:108125. doi: 10.1016/j.intimp.2021.108125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.108125</ArticleId><ArticleId IdType="pmc">PMC8426217</ArticleId><ArticleId IdType="pubmed">34543980</ArticleId></ArticleIdList></Reference><Reference><Citation>Krakauer T., Pradhan K., Stiles B.G. Staphylococcal Superantigens Spark Host-Mediated Danger Signals. Front. Immunol. 2016;7:23. doi: 10.3389/fimmu.2016.00023.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00023</ArticleId><ArticleId IdType="pmc">PMC4735405</ArticleId><ArticleId IdType="pubmed">26870039</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold J.E., Okyay R.A., Licht W.E., Hurley D.J. Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation. Pathogens. 2021;10:763. doi: 10.3390/pathogens10060763.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10060763</ArticleId><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss P. &#x201c;The ancient and the new&#x201d;: Is there an interaction between cytomegalovirus and SARS-CoV-2 infection? Immun. Ageing. 2020;17:14. doi: 10.1186/s12979-020-00185-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-020-00185-x</ArticleId><ArticleId IdType="pmc">PMC7251217</ArticleId><ArticleId IdType="pubmed">32501397</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschini E., Cozzi-Lepri A., Santoro A., Bacca E., Lancellotti G., Menozzi M., Gennari W., Meschiari M., Bedini A., Orlando G., et al. Herpes Simplex Virus Re-Activation in Patients with SARS-CoV-2 Pneumonia: A Prospective, Observational Study. Microorganisms. 2021;9:1896. doi: 10.3390/microorganisms9091896.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9091896</ArticleId><ArticleId IdType="pmc">PMC8465957</ArticleId><ArticleId IdType="pubmed">34576791</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutkowski N., Palkama T., Ciurli C., Sekaly R.P., Thorley-Lawson D., Huber B.T. An Epstein-Barr virus-associated superantigen. J. Exp. Med. 1996;184:971&#x2013;980. doi: 10.1084/jem.184.3.971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.184.3.971</ArticleId><ArticleId IdType="pmc">PMC2192769</ArticleId><ArticleId IdType="pubmed">9064357</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrescu D., Ursea B., Pope M., Ascht A.S., Posnett D.N. Enhanced HIV-1 replication in V&#x3b2;12 T cells due to human cytomegalovirus in monocytes: Evidence for a putative herpesvirus superantigen. Cell. 1995;82:753&#x2013;763. doi: 10.1016/0092-8674(95)90472-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(95)90472-7</ArticleId><ArticleId IdType="pubmed">7671303</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber B.T., Hsu P.N., Sutkowski N. Virus-encoded superantigens. Microbiol. Rev. 1996;60:473&#x2013;482. doi: 10.1128/mr.60.3.473-482.1996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mr.60.3.473-482.1996</ArticleId><ArticleId IdType="pmc">PMC239452</ArticleId><ArticleId IdType="pubmed">8840782</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Griffin S., Gurdasani D., Hamdy A., Katzourakis A., McKee M., Michie S., Pagel C., Roberts A., Yates K. Covid-19: An urgent call for global &#x201c;vaccines-plus&#x201d; action. BMJ. 2022;376:111. doi: 10.1136/bmj.o1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o1</ArticleId><ArticleId IdType="pubmed">34980603</ArticleId></ArticleIdList></Reference><Reference><Citation>LeClaire R.D., Bavari S. Human antibodies to bacterial superantigens and their ability to inhibit T-cell activation and lethality. Antimicrob. Agents Chemother. 2001;45:460&#x2013;463. doi: 10.1128/AAC.45.2.460-463.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.45.2.460-463.2001</ArticleId><ArticleId IdType="pmc">PMC90313</ArticleId><ArticleId IdType="pubmed">11158741</ArticleId></ArticleIdList></Reference><Reference><Citation>Zambrano L.D., Newhams M.M., Olson S.M., Halasa N.B., Price A.M., Boom J.A., Sahni L.C., Kamidani S., Tarquinio K.M., Maddux A.B., et al. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12&#x2013;18 Years&#x2014;United States, July&#x2013;December 2021. MMWR Morb. Mortal. Wkly. Rep. 2022;71:52&#x2013;58. doi: 10.15585/mmwr.mm7102e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7102e1</ArticleId><ArticleId IdType="pmc">PMC8757620</ArticleId><ArticleId IdType="pubmed">35025852</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin E.G., Lustig Y., Cohen C., Fluss R., Indenbaum V., Amit S., Doolman R., Asraf K., Mendelson E., Ziv A., et al. Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months. N. Engl. J. Med. 2021;385:e84. doi: 10.1056/NEJMoa2114583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2114583</ArticleId><ArticleId IdType="pmc">PMC8522797</ArticleId><ArticleId IdType="pubmed">34614326</ArticleId></ArticleIdList></Reference><Reference><Citation>Choe P.G., Kang C.K., Suh H.J., Jung J., Song K., Bang J.H., Kim E.S., Kim H.B., Park S.W., Kim N.J., et al. Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection. Emerg. Infect. Dis. 2021;27:327&#x2013;329. doi: 10.3201/eid2701.203515.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2701.203515</ArticleId><ArticleId IdType="pmc">PMC7774548</ArticleId><ArticleId IdType="pubmed">33050983</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh J., Pandit P., McArthur A.G., Banerjee A., Mossman K. Evolutionary trajectory of SARS-CoV-2 and emerging variants. Virol. J. 2021;18:166. doi: 10.1186/s12985-021-01633-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-021-01633-w</ArticleId><ArticleId IdType="pmc">PMC8361246</ArticleId><ArticleId IdType="pubmed">34389034</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence of Ongoing Symptoms Following Coronavirus (COVID-19) Infection in the UK: 3 March 2022, Office for National Statistics.  [(accessed on 7 February 2022)]; Available online:  https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/3march2022.</Citation></Reference><Reference><Citation>Falasinnu T., Chaichian Y., Simard J.F. Impact of Sex on Systemic Lupus Erythematosus-Related Causes of Premature Mortality in the United States. J. Women&#x2019;s Health. 2017;26:1214&#x2013;1221. doi: 10.1089/jwh.2017.6334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jwh.2017.6334</ArticleId><ArticleId IdType="pmc">PMC5695737</ArticleId><ArticleId IdType="pubmed">28891746</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen T.M., Andersen N.H., Torp-Pedersen C., S&#xf8;gaard P., Kragholm K.H. Kawasaki disease, autoimmune disorders, and cancer: A register-based study. Eur. J. Pediatr. 2020;180:717&#x2013;723. doi: 10.1007/s00431-020-03768-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-020-03768-4</ArticleId><ArticleId IdType="pmc">PMC7415012</ArticleId><ArticleId IdType="pubmed">32772155</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Jimenez J.L., Prather K.A., Tufekci Z., Fisman D., Schooley R. Ten scientific reasons in support of airborne transmission of SARS-CoV-2. Lancet. 2021;397:1603&#x2013;1605. doi: 10.1016/S0140-6736(21)00869-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00869-2</ArticleId><ArticleId IdType="pmc">PMC8049599</ArticleId><ArticleId IdType="pubmed">33865497</ArticleId></ArticleIdList></Reference><Reference><Citation>Desforges M., Gurdasani D., Hamdy A., Leonardi A.J. Uncertainty around the Long-Term Implications of COVID-19. Pathogens. 2021;10:1267. doi: 10.3390/pathogens10101267.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10101267</ArticleId><ArticleId IdType="pmc">PMC8536991</ArticleId><ArticleId IdType="pubmed">34684216</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonardi A.J., Argyropoulos C.P., Hamdy A., Proenca R.B. Understanding the Effects of Age and T-Cell Differentiation on COVID-19 Severity: Implicating a Fas/FasL-mediated Feed-Forward Controller of T-Cell Differentiation. Front. Immunol. 2022;13:606. doi: 10.3389/fimmu.2022.853606.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.853606</ArticleId><ArticleId IdType="pmc">PMC8927653</ArticleId><ArticleId IdType="pubmed">35309371</ArticleId></ArticleIdList></Reference><Reference><Citation>Showers W.M., Leach S.M., Kechris K., Strong M. Longitudinal analysis of SARS-CoV-2 spike and RNA-dependent RNA polymerase protein sequences reveals the emergence and geographic distribution of diverse mutations. Infect. Genet. Evol. 2021;97:105153. doi: 10.1016/j.meegid.2021.105153. ISSN 1567-1348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2021.105153</ArticleId><ArticleId IdType="pmc">PMC8600767</ArticleId><ArticleId IdType="pubmed">34801754</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>